Is My Patient Taking an Unsafe Dietary Supplement?

Area of Science:

• Pharmacology
• Public Health
• Clinical Medicine

Background:

• Dietary supplements are widely used but not premarket approved by the US Food and Drug Administration (FDA).
• Supplements can cause adverse effects, interact with medications, and pose safety concerns.
• Clinicians play a crucial role in guiding patients regarding supplement use.

Purpose of the Study:

• To provide an overview of regulatory requirements for dietary supplements.
• To discuss safety, manufacturing, labeling, advertising, and adverse event reporting for supplements.
• To offer clinical recommendations for healthcare providers regarding dietary supplement use.

Main Methods:

• Review of US Food and Drug Administration (FDA) and Federal Trade Commission (FTC) regulations.
• Analysis of enforcement actions related to tainted and unsafe dietary supplements.
• Synthesis of clinical and ethical considerations for healthcare providers.

Main Results:

• Dietary supplements are subject to regulations concerning safety, manufacturing, and labeling, but not premarket approval.
• Tainted supplements and misleading advertising are significant concerns, leading to FDA and FTC enforcement actions.
• Clinicians need to be aware of potential supplement-drug interactions and adverse events.

Conclusions:

• Open communication between clinicians and patients about dietary supplement use is essential.
• Healthcare providers should be knowledgeable about supplement regulations and potential risks.
• Proactive guidance from clinicians can mitigate adverse outcomes associated with dietary supplement consumption.